APA (7th ed.) Citation

K, L., Y, R., D, C., Z, Z., H, B., A, Q., . . . J, W. (2020). Combination of Ruthenium Complex and Doxorubicin Synergistically Inhibits Cancer Cell Growth by Down-Regulating PI3K/AKT Signaling Pathway. Frontiers in oncology, 10, 141. https://doi.org/10.3389/fonc.2020.00141

Chicago Style (17th ed.) Citation

K, Lin, Rong Y, Chen D, Zhao Z, Bo H, Qiao A, Hao X, and Wang J. "Combination of Ruthenium Complex and Doxorubicin Synergistically Inhibits Cancer Cell Growth by Down-Regulating PI3K/AKT Signaling Pathway." Frontiers in Oncology 10 (2020): 141. https://doi.org/10.3389/fonc.2020.00141.

MLA (9th ed.) Citation

K, Lin, et al. "Combination of Ruthenium Complex and Doxorubicin Synergistically Inhibits Cancer Cell Growth by Down-Regulating PI3K/AKT Signaling Pathway." Frontiers in Oncology, vol. 10, 2020, p. 141, https://doi.org/10.3389/fonc.2020.00141.